MedTrace Logo

High Water Intake in Polycystic Kidney Disease

NCT02933268 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2019-01-15

No results posted yet for this study

Summary

DRINK is an open-label randomised controlled feasibility trial of high versus ad libitum water intake in ADPKD.

Conditions

  • Autosomal Dominant Polycystic Kidney Disease

Interventions

DIETARY_SUPPLEMENT

High water intake

High water intake aimed at achieving an urine osmolality \< 270mOsmo/kg. Individualised prescription for each participant based on the free water clearance formula calculation.

OTHER

Ad libitum water intake

Water intake guided by thirst

Sponsors & Collaborators

  • PKD Charity

    collaborator UNKNOWN

  • Addenbrookes Charitable Trust

    collaborator OTHER

  • British Renal Society & British Kidney Patient Association

    collaborator UNKNOWN

  • Cambridge University Hospitals NHS Foundation Trust

    lead OTHER

Principal Investigators

  • Thomas F Himestra · Cambridge University Hospital NHS Foundation Trust

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-26
Primary Completion
2018-03-31
Completion
2018-07-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02933268 on ClinicalTrials.gov